Lasa Supergenerics opened at ₹5.16, in line with its previous close of ₹5.16. During today's session, the stock has traded between ₹4.91 and ₹5.39, with an average traded price of ₹4.93. It is currently showing a downward intraday trend.
An investment of ₹10,000 made 4 years ago in Lasa Supergenerics is now worth
₹ 10,000.00
giving a profit of
₹ 0.00 (0.00%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
-0.25 (-4.85%)
Day High
₹5.39
Day Low
₹4.91
Day Open
₹5.16
Prev Close
₹5.16
Volume
37,588
Value Traded
₹0.02 Cr
1W Return
0.00%
1M Return
0.00%
3M Return
-32.74%
6M Return
-39.23%
1Y Return
-51.34%
Market Cap (₹ Cr.)
25
PE Ratio
-1.70
PB Ratio
0.56
Dividend Yield
3.83%
ROE
-68.70%
ROCE
-69.14%
Book Value (₹)
9.90
Face Value (₹)
10.00
EPS (TTM)
-
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
0.00%
6 Week
-
1 Month
0.00%
3 Month
-32.74%
9 Month
-46.86%
No data available.
Lasa Supergenerics appoints Janardan Savala as executive director
Janardan Savala appointed as Executive Director for five years from August 26, 2026. Dr. Omkar Herlekar re-appointed as director after retiring by rotation. 11th AGM scheduled for September 30, 2026, via video conferencing. Board seeks approval for ₹2 crore annual donation limit and ₹3 crore managerial remuneration cap. Borrowing powers approved to repay disputed external loans.
1mo agoLasa Supergenerics appoints Janardan Savala as additional executive director
Janardan Kamlu Savala appointed as additional executive director on August 26, 2026. Term spans five years until August 25, 2031. Appointment requires shareholder approval via general meeting or postal ballot. Savala brings expertise in banking coordination and compliance processes.
1mo agoLasa Supergenerics accepts Ganesh Potdar resignation as WTD
Ganesh Potdar resigns as Additional Director and Whole Time Director. Effective date is closing hours of August 25, 2026. Cited personal commitments as the sole reason for departure. No other material reasons disclosed for the resignation. Compliance filed under Regulation 30 of SEBI LODR 2015.
1mo agoLasa Supergenerics promoter reports no new encumbrance in FY26
Omkar Herlekar, a promoter of Lasa Supergenerics Limited, confirmed in a filing dated April 7, 2026, that he did not create any new encumbrance on shares during the financial year ended March 31, 2026. The declaration, compliant with SEBI (SAST) Regulations, 2011, confirms that no shares were pledged beyond those previously disclosed.
4mo agoLASA Supergenerics discloses related party transactions for Q4FY26
LASA Supergenerics Limited disclosed related party transactions for Q4FY26, reporting ₹35.36 lakh in actual transactions against an approved limit of ₹618 lakh. Payments included remuneration for directors and a donation to the Dr Omkar Herlekar Foundation.
4mo agoLasa Supergenerics narrows net loss to ₹416.44 lakh in Q4FY26
Lasa Supergenerics narrowed its net loss to ₹416.44 lakh for Q4FY26 from ₹1,429.11 lakh in Q4FY25, with revenue from operations falling to (₹13.15) lakh due to a production halt caused by a fire incident. The statutory auditor, Gupta Rustagi & Co., issued a qualified opinion due to insufficient evidence on the fire's financial impact and the lack of impairment assessment for intangible assets worth ₹1,667.05 lakh. For the full year FY26, the company reported a net loss of ₹3,409.03 lakh on a total income of ₹2,534.05 lakh, while facing operational challenges like labour unrest.
4mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,743.00 | -0.90% | ₹4,18,204.09 | 34.85 | +5.06% | |
| ₹9,087.00 | -0.63% | ₹2,41,231.30 | 83.68 | +37.67% | |
| ₹4,558.70 | -0.00% | ₹1,73,398.29 | 80.45 | +29.00% | |
| ₹2,069.00 | +0.43% | ₹1,11,790.60 | 102.03 | +137.04% | |
| ₹1,113.90 | -0.81% | ₹1,11,111.95 | 24.42 | +13.13% | |
| ₹1,324.10 | -0.08% | ₹1,06,968.54 | 31.90 | -15.63% | |
| ₹1,242.50 | +0.77% | ₹1,03,709.03 | 32.30 | +0.19% | |
| ₹1,621.40 | -2.73% | ₹93,291.77 | 25.74 | +46.56% | |
| ₹2,253.20 | -0.98% | ₹93,067.32 | 45.45 | -8.23% | |
| ₹1,939.20 | -1.14% | ₹88,677.67 | 16.11 | -0.62% | |
| ₹2,210.20 | -0.74% | ₹62,377.30 | 34.91 | +18.55% | |
| ₹5,004.00 | -0.91% | ₹59,830.33 | 27.42 | -9.41% |
An investment of ₹10,000 made 4 years ago in Lasa Supergenerics is now worth
₹ 10,000.00
giving a profit of
₹ 0.00 (0.00%)
Note: Past profits do not guarantee future returns.